Abstract We examined the relationship between reproductive factors and risk of premenopausal breast cancer among women less than age 40 compared with older premenopausal women. We documented 374 incident cases of breast cancer diagnosed before age 40, and 2,533 cases diagnosed at age 40 and older among premenopausal women in the Nurses' Health Study cohorts. Biennial questionnaires were used to determine age at menarche, age at first birth, parity, breastfeeding, and other reproductive factors. Multivariate relative risks (RR) and 95 % confidence intervals (CI) were calculated using Cox proportional hazards models within age at diagnosis groups. Tumors in younger women were significantly more likely to be higher grade, larger size, and hormone receptor negative than were tumors in older premenopausal women (p \ 0.0001). There was no significant heterogeneity according to age in associations between reproductive factors and risk of premenopausal breast cancer. First birth at age 30 or older increased breast cancer risk in both age groups (age \40: RR 1.10, 95 % CI 0.80-1.50; age C40: RR 1.16, 95 % CI 1.02-1.32; p-heterogeneity = 0.44). Risk of premenopausal breast cancer decreased with each additional year of age at menarche in both age groups (age \40: RR 0.93, 95 % CI 0.87-0.99; p trend = 0.02; age C40: RR 0.94, 95 % CI 0.91-0.97; p trend = \0.0001). Among premenopausal parous women, breastfeeding was protective regardless of age at diagnosis (age \40: RR 0.84, 95 % CI 0.57-1.22; age C40: RR 0.85, 95 % CI 0.72-0.99; p-heterogeneity = 0.79). In the largest prospective examination of reproductive risk factors and risk of breast cancer before and after age 40, we found that younger women were more likely to develop tumors with less favorable prognostic characteristics. However, associations between reproductive factors and risk of breast cancer were similar regardless of age at diagnosis of premenopausal breast cancer.
Introduction
Breast cancer is the most commonly diagnosed cancer among women, with an estimated 232,340 new cases diagnosed in 2013 [1] . About 7 % of those breast cancers were diagnosed among women \40 years of age [1, 2] . While incidence is relatively low, breast cancer represents about 40 % of all cancers diagnosed among these young women. Breast cancer incidence rates among women younger than 40 years of age have been stable for the last three decades [3] [4] [5] . However, a recent report suggests that only the incidence of local and regional tumors has been stable among 20-39 year olds, while incidence of distant breast cancer increased by 2 % per year between 1978 and 2008 [6] .
Owing to the low incidence rates among this age group, few reports address breast cancer in young women, and many studies that have been conducted use a case-control design [7] . Much of the prospective data available on breast cancer in young women are from studies examining premenopausal breast cancer, where authors did sub-analyses stratified by age to examine potential effect modification [8, 9] . In addition, there is little consistency in the definition of young. Age cutoffs of 45, 40 , and 35 can all be found in the literature [4, [10] [11] [12] [13] [14] [15] . Studies have also used inconsistent comparison groups when comparing tumor characteristics in younger vs older women with breast cancer, and sometimes have been a mixture of pre and postmenopausal women [16] . There are known clear distinctions in tumor characteristics and risk factors between pre and postmenopausal women; therefore, these comparisons may be of limited utility.
Some authors have suggested that the breast cancer occurring in women before the age of 40 may be etiologically and clinically distinct from cancers occurring in older women [17] [18] [19] [20] . At diagnosis, younger women tend to have larger tumors, a higher proportion of late stage, high grade, and are more likely to be estrogen receptor negative (ER-) [15, 21, 22] . There has been inconsistency in findings regarding human epidermal growth receptor 2 (HER-2) expression [23] [24] [25] [26] , though a recent article showed that adolescent and young adult women in California had higher proportions of HER-2 positive tumors than did older women [27] . Differences in stage and tumor size are likely , at least in part, because that these women have not reached the recommended age for mammography, while differences in grade and estrogen receptor status may be more indicative of differences in etiology [28] . Tumors in women diagnosed at a young age share a pattern of gene expression which differentiates them from tumors diagnosed in older women, but there is conflicting evidence whether this difference is attributable to differences in tumor subtype distributions across age groups [29] [30] [31] . Several studies have demonstrated that young women have an increased risk of disease recurrence and death compared with older women [32, 33] , though it is difficult to disentangle the effects of age from those of tumor characteristics. Yet, several studies suggest that age is an independent prognostic factor, and this association may vary by tumor subtype and stage at diagnosis [34, 35] . Understanding risk factors for breast cancer among young women, particularly within subtypes, is critical.
Reproductive factors are the group of factors with the strongest and most consistent associations with breast cancer risk [36] . Known factors associated with premenopausal breast cancer include age at menarche, age at first birth, and parity. Later age at menarche and earlier age at first birth are consistently associated with lower risk of breast cancer, though there are known differences between estrogen and progesterone hormone statuses [37] [38] [39] [40] . Several studies have shown interaction between the effect of parity by age, such that at younger ages (and closer in time to the birth) parous women experience an increased risk of breast cancer, while at older ages parity is protective [14, 36, [41] [42] [43] . Prior studies have included relatively few women of age less than 40 at diagnosis, and it remains unclear if these differences in risk exist among young women, and if similar differences in associations exist for other reproductive factors including breastfeeding and interval between menarche and first live birth.
The purpose of this study was to examine the relationship between reproductive factors and breast cancer risk among women\40 years of age overall, and according to subtypes defined by estrogen and progesterone receptor statuses, in a large prospective cohort study. We also assessed whether associations differ between premenopausal women \40 years of age and those of age 40 or older.
Materials and methods

Study population
The Nurses' Health Studies (NHS I and NHS II) are ongoing prospective cohort studies of female, registered nurses across the United States [44] . In 1976, 121,700 female registered of ages 30-55 years and of primarily Caucasian descent, were enrolled in NHS I. NHS II began in 1989 with 116,608 largely Caucasian female registered nurses ages of 25 and 42. Nurses have complete biennial mailed questionnaires that comprise items about their health status, medical history, and known or suspected risk factors for cancer. Institutional Review Board approval for this study was obtained from Partners Healthcare Human Research Committee.
For analyses of the risk of premenopausal breast cancer diagnosed before age 40, women were excluded if at baseline they were of age 40 or older (n = 94,337), were not premenopausal (n = 7,156), have reported a previous cancer diagnosis (n = 1,433), or were diagnosed with breast cancer before baseline (n = 51). Women stopped contributing person-time at the first report of any of the following events: reached 40 years of age, onset of menopause, breast cancer diagnosis, diagnosis of any other cancer (excluding non-melanoma skin cancer), or death.
Otherwise, follow-up ended in June 2009. There were 374 confirmed, incident invasive breast cancers diagnosed in premenopausal women \40 years of age.
For analyses of the risk of premenopausal breast cancer diagnosed at age 40 or older, women were excluded if at baseline they were not premenopausal (n = 39,217), had breast cancer diagnosed before baseline (n = 95), or have reported a previous other cancer diagnosis (n = 1,861). Women started contributing person-time in the first data cycle in which they were of age 40 or older and stopped at the first report of any of the following events: onset of menopause, breast cancer diagnosis, diagnosis of any other cancer (excluding non-melanoma skin cancer), or death.
Otherwise, follow-up ended in June 2009. There were 2,533 confirmed, incident invasive breast cancers diagnosed in premenopausal women of age 40 or older.
Outcome assessment
Incident breast cancer diagnoses on each biennial questionnaire are, with participant or next of kin permission, confirmed through medical record review. Pathology reports are also requested, and information on tumor characteristics including grade, stage, and hormone receptor status is obtained. Deaths are reported through family members or identified through review of the National Death Index.
Exposure assessment
At baseline, participants reported their number of births, age at each birth, and age at menarche; history of breast cancer or any other cancers, history of benign breast disease, height and weight, age at menarche, oral contraceptive (OC) use, family history of breast cancer, alcohol consumption; and menopausal status. In subsequent biennial questionnaires, they reported any new diagnoses of breast cancer, and updated information on baseline factors including births, OC use, benign breast disease, and menopausal status. Breastfeeding was assessed in 1986 in NHS and in 1993 and 1997 in NHS II. As there were no breast cancers diagnosed among women less than age 40 after the 1986-1988 cycle in NHS, we have limited the analyses of breastfeeding to NHS II. As the last information on parity for women in NHS was collected in 1996, we have carried this value forward for all subsequent time periods.
In analyses restricted to parous women, we examined the relationship between time since last birth, interval between menarche and first birth, age at first birth, number of births, and breastfeeding with risk of breast cancer. Interval between menarche and first birth is calculated as the age at first birth minus age at menarche. Time since last birth is calculated as the date of return of the most recent questionnaire minus the date of last reported birth. Information on age at first birth, parity, and menopausal status was updated through biennial questionnaires, and person time was reassigned using updated information every 2 years. Missing indicators were used for missing reproductive exposure data, and covariate data were carried forward for up to two questionnaire cycles.
Statistical analysis
The distributions of hormone receptor status, tumor size and grade, lymph node involvement, and initial sign or symptom of cancer among women diagnosed less than age 40 were compared with premenopausal women of age 40 and older using Chi square tests (for categorical variables) and Mantel-Haenszel Chi square tests for trend (for ordinal variables). Cox proportional hazards regression models were used to estimate hazard ratios and 95 % confidence intervals (CI) for breast cancer associated with each established premenopausal breast cancer risk factor stratified by age at diagnosis (\40 and C40). Age and multivariate adjusted models are presented. Multivariate models are adjusted for age (continuous), BMI at age 18 (kg/m 2 ), weight change since age 18 (kg), alcohol intake (g/day), height (meters), family history (first degree relative vs. none), and history of benign breast disease (yes/no).
We tested for heterogeneity by age at diagnosis using likelihood ratio tests by comparing models with and without interaction terms for continuous exposures and a binary indicator of age. To evaluate the consistency of risk estimates among hormone receptor types defined by estrogen and progesterone receptor statuses jointly (ER-PR-or ER?PR?), we performed a competing risks analysis allowing estimates to vary for all reproductive exposure variables [45] [46] [47] . Likelihood ratio tests were used to compare a model having different slopes for each hormone receptor status with that having common slope. Chi square tests are used to obtain two-sided p values for all likelihood ratio statistics.
Results
The distribution of traditional premenopausal breast cancer risk factors at baseline according to age group is shown in Table 1 . Women younger than age 40 were more likely to be nulliparous (25 vs. 9 %) and current OC users (15 vs. 6 %), and were less likely to be currently obese (9 vs. 11 %) and to have had their first menstrual cycle at age 14 or older (18 vs. 20 %) than were women of age 40 and older. The distribution of BMI at age 18 was similar between groups. Women younger than 40 were more likely to report a current BMI \20 (17 %) than were those of age 40 and older (10 %).
Mean age at diagnosis was 36.8 years among women diagnosed with breast cancer before age 40 and 48.2 years for women diagnosed at age 40 or older (Table 2) . Younger women were more likely to be diagnosed with hormone receptor negative, higher grade, and larger tumors compared with older premenopausal women. For example, 30 % of tumors were estrogen and progesterone receptor negative (ER-PR-) among women diagnosed before age 40, while 19 % were for women of age 40 or older (p \ 0.0001). Younger women were somewhat more likely to be diagnosed at a later stage, with 19 % diagnosed at stage III compared to 15 % of women of age 40 or older at diagnosis (p = 0.03).
Associations with age at menarche and breast cancer risk were similar in both age groups (Table 3 ). Women experiencing menarche at age 14 or older were 24 % less likely to develop breast cancer before age 40 (RR 0.76, 95 % CI 0.55-1.04; p trend = 0.02) and were 11 % less likely to develop breast cancer at age 40 or older (RR 0.89, 95 % CI 0.79-1.00; p trend \ 0.0001). Women with an age at first birth of age 30 or older were at a higher risk of premenopausal breast cancer compared with nulliparous women in both age groups (age \40: RR 1.10, 95 % CI 0.80-1.50; age C40: RR 1.16, 95 % CI 1.03-1.30; p heterogeneity = 0.32). In each age group, women with three or more births had a lower breast cancer risk compared with nulliparous women (age \40: RR 0.78, 95 % CI 0.56-1.08; age C40: RR 0.84, 95 % CI 0.73-0.97). When stratified by breastfeeding in both age groups, we observed no protective association of parity among women who never breastfed (age\40: RR 1.14, 95 % CI 0.71-1.83; age C40: RR 0.93, 95 % CI 0.75-1.14). Premenopausal women of age 40 or older with two or more children who had ever breastfed (RR: 0.84, 95 % CI: 0.70-0.94) or had a last birth 10 or more years ago (RR 0.81, 95 % CI 0.70-0.94) were at a reduced risk of breast cancer. Such associations were not observed among those younger than 40.
Among parous women, long duration between menarche and first birth was associated with an increased risk of breast cancer among premenopausal women of age 40 or older at diagnosis (Table 4) . Among older women, having 15 or more years between menarche and first birth was associated with a 21 % increased risk of breast cancer (RR 1.21, 95 % CI 1.04-1.42) compared to those having \5 years. That same interval was associated with a nonstatistically significant increase in risk (RR 1.17, 95 % CI 0.75-1.80) among younger women. Among premenopausal We did not observe a significant trend for breastfeeding duration in either age group, although the suggested direction of associations was similar. Among women younger than 40, earlier age at menarche was associated with an increased risk of breast cancer in both ER?PR? and ER-PR-tumors, though results were not statistically significant for the latter (Table 5 ). For ER?PR? tumors, women with an age at menarche of age 14 or older were 50 % less likely to be diagnosed with breast cancer than those with an age of menarche of less than 12 (RR: 0.50, 95 % CI: 0.28, 0.90). While the observed associations between age at first birth and age at menarche were similar across hormone receptor groups among young women, there was a significant heterogeneity for parity (ER?PR?: RR 0.97, 95 % CI 0.59-1.60; ER-PR-: RR 1.79, 95 % CI 0.92-3.50; p-heterogeneity = 0.048). We observed no differences in risk patterns by ERPR status among women of age 40 or older.
Discussion
We examined types of tumors diagnosed, relationships between age at menarche, age at first birth and parity, and birth timing characteristics, and risks of premenopausal breast cancer before and after age 40. Younger premenopausal women were diagnosed with more hormone receptor negative, larger size, and higher grade tumors compared with older premenopausal women. We did not observe evidence of differing associations for the reproductive factors that we studied according to age at diagnosis. The associations with age at first birth, parity and age at menarche, and premenopausal breast cancer risk were similar across age groups at diagnosis. We further investigated whether the associations of these factors varied by hormone receptor type. Among women in both age groups increasing parity appeared protective for ER?PR? tumors, while it was associated with increased risk for ER-PR tumors.
In our study, we expected parity and shorter times since last birth to be associated with increased risk of breast cancer among younger women. However, we did not observe any increased risk associated with parity or time since last birth women among women younger than 40. Given the small number of breast cancers diagnosed among women before age 40, it is possible that we lacked the power to observe any possible increased risk, though our results suggest a protective association (RR 0.82, 95 % CI 0.59-1.14). More in line with our hypothesis, for time since last birth, we observed that women with 2-4 years since last pregnancy had a nonstatistically significant 73 % increase in risk of premenopausal breast cancer (RR 1.73, 95 % CI 0.93-2.00). Second, in prior studies ''older'' women included postmenopausal women, whereas our study is restricted to premenopausal women and therefore it has a narrower range of ages included. The ''older'' women in our study may not be old enough, or far enough removed from childbearing, to fully observe the expected association. Third, the increased risk of breast cancer is observed largely with first pregnancy and is the strongest in women having their first child after age 35. Given that our analysis of young women was restricted to women younger than 40, there was limited opportunity for births after age 35, and overall there were relatively fewer births for women of age 35 or older in these two cohorts (NHS I, 3.5 %; NHS II, 3.6 %). Finally, given the known differences in association between reproductive factors and breast cancer subtypes, our results may have been influenced by differences in hormone receptor status between women diagnosed before and after age 40. Our finding that for both age groups, parity was inversely associated with risk of ER?PR? tumors, but positively associated with risk of ER-PR-tumors is consistent with some previous literature [48, 49] . However, several studies have found that parity is not associated with risk of ER-breast cancer [39, 50, 51] . Some reports show breastfeeding to be more strongly associated with a reduced risk of ER-tumors than ER? tumors [48, [52] [53] [54] , and that breastfeeding may eliminate any increased breast cancer risk associated with parity [48, 52, 54] . However, we did not observe the same in our study. Breastfeeding was similarly associated with reduced risk of breast cancer for ER?PR? and ER-PR-tumors across age at diagnosis strata. Our examination of cross-classified breastfeeding and parity was limited by small case numbers, particularly among women diagnosed before age 40. There was, however, a suggestion of increased risk of ER-PR-tumors before age 40 for women with two or more children who had never breastfed.
With 374 cases diagnosed among women before age 40, we had limited statistical power for several analyses, resulting in wide CI and nonsignificant p values. For example, we were unable to examine whether the association between family history and breast cancer differed by age at diagnosis because only 28 cases under age 40 reported a family history. Additional follow-up in these cohorts will not yield additional incident cases in our group less than 40 years, as by the study cutoff date, all the women in both cohorts were older than age 40. Nevertheless, to our knowledge, this analysis represents the largest prospective examination of the relationship between reproductive factors and premenopausal breast cancer in women younger than 40 and the first comparison with premenopausal women of age 40 or older.
We were unable to examine the role of genetic mutations such as BRCA 1 and 2 in this analysis. Women diagnosed before age 40 are more likely to have a family history of breast cancer (in first-or second-degree relatives), and are more likely than older women to have BRCA 1 and/or 2 mutations. In this analysis, we used family history as a proxy for genetic susceptibility [55] . Research suggests that the role of genetics in breast cancer etiology increases with younger age at diagnosis and more extensive family history [56] . While these genetic mutations are of relatively more importance in younger compared with older women, their absolute contribution to risk remains low. For example, in a population-based study, only 4.9 % of cases were found to have BRCA 1 and/or 2 mutations [57] . Thus, we believe that this is unlikely to have biased our results.
Breast cancer in women younger than 40 is the most common among African-American women [58] [59] [60] , of whom there are only a very few in this sample. Our results may not be generalizable to African-American women since their subtype distribution may differ from what we have observed in our cohorts [52, [61] [62] [63] , and the higher rates of breast cancer before age 40 in African-American women appear to be driven by subtype-specific differences [64] . Also, because we lacked sufficient data on HER-2 among the young cases that were generally diagnosed early in the follow-up period of both cohorts, we were unable to determine the distribution of triple-negative tumors or other subtypes.
This study is one of the first to prospectively examine the relationship of reproductive factors with risk of premenopausal breast cancer risk according to age. We found little evidence of differing associations between age at first birth, parity and age at menarche, and risk of premenopausal breast cancer among women diagnosed before and after age 40. used in this publication were obtained from the DPH. The authors assume full responsibility for analyses and interpretation of these data.
